Joint-Development Agreement to Bring TiO2-Based Nanowires to Market

Today, IP2Biz LLC of Atlanta and International Speciality Chemicals Ltd. (ISC) of London, announced a joint-development agreement for the purpose of bringing titanium dioxide (TiO2)-based nanowires to market. The two companies will work together to develop manufacturing capabilities and identify additional applications for this unique, breakthrough material created at the University of Arkansas. Financial details of the agreement were not disclosed.

When assembled into free-standing membranes, this two-dimensional “paper” provides solutions for a variety of applications including high-temperature chemical and water filtration, high-temperature non-woven textiles, drug delivery, fuel cells and solar cells among others.

“While speciality filtration applications appear to be the first addressable market segment, we fully expect to see many other applications come to market based on our knowledge of TiO2 and our global network of suppliers and customers,” said David Priestley, managing director of ISC, the London-based manufacturer and distributor of chemical products.

“The long nanowires are nearly pure TiO2,” commented James Throckmorton, president of IP2Biz, the Atlanta-based company that holds the global license for the technology. “In addition to withstanding extreme temperatures, TiO2-based nanowires can be used in the strongest chemical acids and bases. We look to multiple breakthrough applications in the future.”

The technology is licensed exclusively to IP2Biz through the University of Arkansas Technology Development Foundation, an organization that helps transfer early-stage inventions to corporations and start-up organizations.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.